Total syntheses of HMP-Y1, hibarimicinone, and HMP-P1.

Total syntheses of HMP-Y1, hibarimicinone, and HMP-P1.
复制标题

DOI:
10.1021/ja307207q
复制
发表时间:
2012-10-10
影响因子:
15
通讯作者:
Shair, Matthew D.
Shair, Matthew D.
中科院分区:
化学1区
文献类型:
--
作者:
Liau, Brian B.;Milgram, Benjamin C.;Shair, Matthew D.

文献摘要

参考文献

被引文献

相似文献

使用双向合成策略描述了 HMP-Y1、atrop-HMP-Y1、hibarimicinone、atrop-hibarimicinone 和 HMP-P1 的全合成。开发了一种新型的氟化苄迈克尔-克莱森反应序列,通过对称、双向、双环化构建 HMP-Y1 和 atrop-HMP-Y1 的完整碳骨架。通过将 HMP-Y1 衍生物转化为 hibarimicinone 和 HMP-P1,实现了仿生单氧化作用,使受保护的 HMP-Y1 去对称。开发了双向不对称双环化和仿生醚化来构建 hibarimicinone、atrop-hibarimicinone 和 HMP-P1 的多环和高氧化骨架。外消旋联芳基前体的使用允许合成两种hibarimicinone阻转异构体,并首次证实了atrop-hibarimicinone的结构。此外,这项工作首次报道了阿托品-hibarimicinone、HMP-Y1、atrop-HMP-Y1 和 HMP-P1 的完整表征。最后,发现了关于 hibarimicinone C2-C2' 键的 pH 依赖性旋转屏障,这为实现 hibarimicinone 糖基化同系物的合成提供了必要的有价值的信息。
Total syntheses of HMP-Y1, atrop-HMP-Y1, hibarimicinone, atrop-hibarimicinone, and HMP-P1 are described using a two-directional synthesis strategy. A novel benzyl fluoride Michael–Claisen reaction sequence was developed to construct the complete carbon skeleton of HMP-Y1 and atrop-HMP-Y1 via a symmetrical, two-directional, double annulation. Through efforts to convert HMP-Y1 derivatives to hibarimicinone and HMP-P1, a biomimetic mono-oxidation to desymmetrize protected HMP-Y1 was realized. A two-directional unsymmetrical double annulation and biomimetic etherification were developed to construct the polycyclic and highly-oxidized skeleton of hibarimicinone, atrop-hibarimicinone, and HMP-P1. The use of a racemic biaryl precursor allowed for the synthesis of both hibarimicinone atropisomers and provides the first confirmation of the structure of atrop-hibarimicinone. Additionally, this work documents the first reported full characterization of atrop-hibarimicinone, HMP-Y1, atrop-HMP-Y1, and HMP-P1. Lastly, a pH-dependent rotational barrier about the C2–C2' bond of hibarimicinone was discovered, which provides valuable information necessary to achieve syntheses of the glycosylated congeners of hibarimicinone.
DOI: 10.1021/ol050105c
发表时间: 2005-04-28
期刊: ORGANIC LETTERS
影响因子: 5.2
作者:
Lee, WD;Kim, K;Sulikowski, GA
通讯作者: Sulikowski, GA
DOI: 10.7164/antibiotics.55.46
发表时间: 2002-01-01
影响因子: 3.3
作者:
Hori, H;Kajiura, T;Oki, T
通讯作者: Oki, T
DOI: 10.7164/antibiotics.51.402
发表时间: 1998-04-01
影响因子: 3.3
作者:
Hori, H;Igarashi, Y;Oka, T
通讯作者: Oka, T
DOI: 10.1021/ol202728v
发表时间: 2011-12-16
期刊: ORGANIC LETTERS
影响因子: 5.2
作者:
Milgram, Benjamin C.;Liau, Brian B.;Shair, Matthew D.
通讯作者: Shair, Matthew D.
DOI: 10.1021/ol048436x
发表时间: 2004-10-14
期刊: ORGANIC LETTERS
影响因子: 5.2
作者:
Narayan, S;Roush, WR
通讯作者: Roush, WR